Myomo Inc, a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the receipt of a $120,000 order for MyoPro units from Cleveland’s Louis Stokes Veterans Administration (VA) Medical Center.
The units will be used in an investigator-initiated, randomized clinical trial led by Svetlana Pundik, MD, Assistant Professor, Department of Neurology, Case Western Reserve University School of Medicine and Director, Brain Plasticity and Neural Recovery Research Laboratory and Staff Neurologist, Louis Stokes Cleveland VA Medical Center. This independent study is further supported by the VA’s Office of Research and Development. Revenue associated with the delivery of these units is expected to begin to be realized in the coming months as study subjects are fitted with their devices.
The primary objective of this trial is to study the efficacy of the MyoPro in motor learning-based therapy for individuals with chronic stroke (>6 months post event) with severe upper limb motor deficits (Fugl-Meyer for Upper Limb score less than 30), compared with motor learning-based therapy alone.
“This study by the Cleveland VA represents an important addition to the established body of evidence documenting the benefits of MyoPro,” said Harry Kovelman, MD, Chief Medical Officer of Myomo Inc. “Randomized clinical trials represent the highest level of research as viewed by clinical professionals and third-party payers. We look forward to sharing the evidence Dr. Pundik and her colleagues will provide in this new study to assess the efficacy of using the Myopro in motor learning-based therapy for individuals suffering with severe upper limb deficits resulting from chronic stroke.”
[Source(s): Myomo Inc, Business Wire]
Related Content:
Myomo Inc Receives New Medicare HCPCS Codes for MyoPro System
